Researchers are conducting a study to understand the impact of experimental medication on smoking cues.
Today, 14% of the population in the United States smokes cigarettes. Many would like to quit and some quit and end up relapsing. Addiction to cigarettes is a massive health care expediture for our country, accounting for 138 billion dollars. We need to understand more about smoking and reducing relapse to it.
The purpose of our research is to understand more about relapse after periods of abstinence that may be driven in part by smoking cues, which trigger craving. This investigation is a crucial stage for treating nicotine dependence. The expected findings should enable researchers to understand if the medication can help reduce your craving to cigarettes.
The purpose of our research is to understand more about relapse after periods of abstinence that may be driven in part by smoking cues, which trigger craving.
Is this study for me?
You may qualify for this study if you meet the following criteria.
Daily smoker for at least one year
Currently smoke an average of at least 5 cigarettes per day
No current diagnosis of a psychotic, eating, developmental or bipolar disorder
What will happen if I participate in the study?
The study has multiple in-person visits to our facilities, including:
An initial phone screen
A medical phone screen
If you qualify, two visits on back-to-back weekdays. In the first visit you will take the medication or placebo and we will measure craving while you are in a virtual reality environment showing smoking cues. 24 hours later you will return and go through the virtual reality environment again while reporting craving. For these two visits you will have to remain abstinent from all nicotine products for a total of 48 hours.
Will I be paid for being in this research study?
Compensation is provided for participation in this study (up to $150).
Will it cost me anything to participate in this study?
There is no cost for you to participate in our research program.